In the fast-paced world of Hollywood, where trends come and go, one topic that continues to captivate the attention of many is the phenomenon of Ozempic.
Originally designed to address Type 2 diabetes, Ozempic, the brand name for the injectable medication semaglutide approved by the FDA in 2017, has now emerged as the latest sensation in the realm of weight loss. As with any health and wellness trend, it has sparked heated discussions online, particularly after the FDA reported a shortage of the drug last August due to surging demand.
Variety first brought to light in September that celebrities had embraced Ozempic as a means to shed excess pounds rapidly, although many of the suspected users have been quick to dismiss the speculations. Notably, Amy Schumer, who experimented with Ozempic a year ago, is now calling out those in Hollywood who remain tight-lipped about their own experiences.
While some stars, such as Chelsea Handler and Dolores Catania from The Real Housewives of New Jersey, have openly discussed their encounters with the medication, others, like Khloe Kardashian and Kyle Richards from The Real Housewives of Beverly Hills, vehemently deny any involvement with Ozempic. Novo Nordisk, the pharmaceutical company responsible for Ozempic, has previously clarified to E! News that the drug is “not approved for chronic weight management.” Instead, its primary purpose is to treat Type 2 diabetes, improve blood sugar levels, and reduce the risk of significant cardiovascular events in adults with the condition.